The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTclarke Regulatory News (CTO)

Share Price Information for Tclarke (CTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 162.50
Bid: 162.50
Ask: 163.00
Change: 0.50 (0.31%)
Spread: 0.50 (0.308%)
Open: 162.00
High: 163.00
Low: 162.00
Prev. Close: 162.00
CTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

30 Nov 2023 07:00

RNS Number : 1128V
TClarke PLC
30 November 2023
 

30 November 2023

TClarke plc

TRADING UPDATE

 

High Quality Order Book Now Exceeds £1.1bn

 

 

TClarke plc ("the Group"), the Building Services Group, today provides an update on current trading and on the outlook for the remainder of the financial year ending 31 December 2023.

 

The Group remains firmly on track to achieve its three-year growth plan target of £500 million revenues in 2023 and expects its year end net cash position to surpass £15 million at 31 December 2023, an increase of £6 million over current market expectations. The Board's revenue and profit expectations for 2024 and 2025 remain unchanged.

 

In addition, the Group is pleased to confirm that its forward order book stood at more than £1.1bn at 31 October 2023; double that of the previous year. This increase in size of order book is reflected across our key market sectors as illustrated below.

Market Sectors

Forward Order Book

(as at Oct 2023)

£m

Forward Order Book

(as at Dec 2022)

£m

%

Increase

Engineering

489

225

117%

Technologies (inc data centres)

355

111

220%

Infrastructure

167

121

38%

Residential

66

73

-10%

FM

29

25

18%

Grand Total

1,106

555

99%

 

Beyond that already secured in the order book, TClarke continues to see significant additional opportunity across all of its core market sectors and the Group is currently selectively tendering for in excess of £1.0bn of additional potential opportunities - providing exceptional further forward visibility and instilling confidence in the Board that the business will continue to expand rapidly into 2024 and 2025 and beyond.

 

 

Notwithstanding the strength of the Company's forward order book, the Group is cognizant that the turbulent prevailing construction sector environment is impacting a number of market participants. As a result, TClarke has made a number of strategic decisions to preserve the business's strong market and financial position. These decisions have included, inter alia:

 

· early contract agreements;

· the changing of some supply chain partners mid contract to protect project completion dates;

 

It is anticipated that projects will continue to be delivered to their project programmes and, as a result of the actions taken in the second half, the Group's 2023 operating profit (EBIT) is now expected to be in the range of £9 million - £10 million.

 

 

Mark Lawrence, Chief Executive, said:

 

"We have now achieved a significant milestone with our secured order book surpassing £1 billion for the first time. This substantial growth positions us well for future success and provides the Board with continued confidence in our ability to deliver a strong performance into 2024 and 2025".

 

-ends-

 

For further information contact:

 

TClarke plc

For further information contact:

 

TClarke plc

Mark Lawrence

Group Chief Executive

Trevor Mitchell

Finance Director

Tel: 020 7997 7400

www.tclarke.co.uk

Cavendish Capital Markets Limited (Corporate Broker)

Ben Jeynes (Corporate Finance)

Dale Bellis / Jasper Berry / Andrew Burdis (Sales and ECM)

Tel: 020 7220 0500

www.cavendish.com

 

RMS Partners

Simon Courtenay

Tel: 020 3735 6551

www.rmspartners.co.uk

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 (AS AMENDED) (WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (AS AMENDED)). UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQKLFLXFLFFBE
Date   Source Headline
8th Mar 20237:00 amRNSTClarke - Preliminary Results
31st Jan 20237:00 amRNSNotice of Investor Presentation
26th Jan 20237:00 amRNSTrading Statement
4th Jan 202312:09 pmRNSBlock listing Interim Review
24th Nov 20227:00 amRNSTrading Statement
1st Nov 20225:13 pmRNSESOT Share Purchase
25th Oct 20222:14 pmRNSESOT Share Purchase
18th Jul 20227:00 amRNSInvestor Presentation
14th Jul 20227:00 amRNSHalf-year Report
5th Jul 202212:12 pmRNSBlock listing 6 Monthly Return
29th Jun 20227:00 amRNSNotice of Investor Presentation
23rd Jun 202210:45 amRNSNotice of Results
22nd Jun 20222:46 pmRNSChange of Auditor
22nd Jun 20229:37 amRNSTotal Voting Rights
17th May 20227:00 amRNSTClarke to Present at Mello Investor Conference
11th May 202210:27 amRNSResult of AGM
11th May 20227:00 amRNSAGM Statement
10th May 202212:51 pmRNSESOT Share Purchase
5th May 20223:52 pmRNSESOT Share Purchase
3rd May 20229:03 amRNSDirector/PDMR Shareholding
26th Apr 20224:29 pmRNSVesting of EIP share awards April 2022
20th Apr 20229:27 amRNSChange of Registered Office
8th Apr 202210:09 amRNSPublication of Annual Report and Notice of AGM
8th Apr 20227:00 amRNSDirectorate Change
16th Mar 20228:27 amRNSDirector/PDMR Shareholding
16th Mar 20228:21 amRNSTotal Voting Rights
11th Mar 20227:00 amRNSInvestor Presentation
9th Mar 20227:02 amRNSDirectorate Change
9th Mar 20227:00 amRNSNotification of Investor Presentation
9th Mar 20227:00 amRNSFinal Results
2nd Feb 20223:21 pmRNSTotal Voting Rights
1st Feb 20227:00 amRNSNotification of Investor Presentation
27th Jan 20227:00 amRNSTrading Statement
4th Jan 202211:28 amRNSBlock listing Interim Review
9th Dec 20211:11 pmRNSESOT Share Purchase
6th Dec 20219:40 amRNSESOT Share Purchase
3rd Dec 202111:51 amRNSTR-1: Notification of Change of Holding
1st Dec 20213:02 pmRNSPDMR Disclosure
1st Dec 20213:00 pmRNSTotal Voting Rights and Share Capital
25th Nov 20217:00 amRNSTrading Statement
18th Oct 20217:00 amRNSInvestor Presentation
6th Oct 202111:14 amRNSPDMR Holding
6th Oct 202111:10 amRNSBlock Listing Application
22nd Sep 20217:00 amRNSNotice of Investor Presentation
17th Aug 20211:41 pmRNSDirector/PDMR Shareholding
9th Aug 20217:00 amRNSTClarke Selected for NHS Smart Buildings Framework
20th Jul 20217:00 amRNSHalf-year Report
5th Jul 20217:00 amRNSBlock listing Interim Review
1st Jul 20217:00 amRNSNotice of Results
1st Jul 20217:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.